FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

FDA Classifies Vision Aid into Class 2

[ Price : $8.95]

Federal Register Final order: FDA classifies the oral electronic vision aid into Class 2.

Safety Audit of FDA Labs Finds Areas for Improvement

[ Price : $8.95]

An HHS workgroup formed after smallpox vials were discovered in an FDA laboratory in 2014 completes an audit of the agencys labora...

DoJ Targeting Corporate Execs

[ Price : $8.95]

The Department of Justice says it is ramping up efforts to target corporate executives who break the law, rather than just their c...

FDA: Pearson Education Marketing Unapproved Device

[ Price : $8.95]

FDA warns Pearson Education that it is marketing its Quotient ADHD System without clearance or approval for the intended uses.

Dramatic Increase in Essure Adverse Events: FDA

[ Price : $8.95]

FDA tells an advisory committee it wants an open discussion about the heightened risks vs. the benefits of Bayers Essure female pe...

Be Vigilant in Clinical Research Compliance: Attorneys

[ Price : $8.95]

Attorneys Julie and Andrew Rusczek offer advice on mitigating risk of fraud and abuse violations in three common clinical research...

FDA Warning Letter Close Out for Bacterin International

[ Price : $8.95]

FDA issues a close-out letter related to a 2013 Warning Letter issued to Belgrade, MO-based Bacterin International.

FDA Clears B. Braun Medical Infusion Pump

[ Price : $8.95]

B. Braun Medical gains FDA 510(k) clearance for its second-generation, large-volume Infusomat Space Pump.

FDA Accepts NDA for Glaucoma Drug

[ Price : $8.95]

FDA accepts for review a Bausch & Lomb and Nicox NDA for Vesneo (latanoprostene bunod ophthalmic solution 0.024%), an intraocular ...

FDA Approves Taiho NDA for Colorectal Cancer

[ Price : $8.95]

FDA approves a Taiho Oncology NDA for Lonsurf (trifluridine and tipiracil), a combination drug for use in patients with an advance...